Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.092 | 0.03 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.082 | 0.07 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.084 | 0.09 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.081 | 0.09 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |